Castor vs Veeva EDC(EDC)

Research teams, sponsors and CROs comparing data collection for clinical trials, from focused participant-centered studies to complex multi-site protocols.

Scope Dedicated EDC systems and participant-centered clinical-trial data collection are compared by their documented capabilities. Whether a participant-centered platform also needs a dedicated EDC depends on in-visit data entry, clinical queries, coding, verification and database-management requirements, rather than study size or trial phase alone.

Guide updated How we compare

Compare within EDC

Study fit, side by side

These notes describe the products in the EDC guide.

Castor

Best for
Academic groups, biotechs and device teams running investigator-initiated or mid-size studies who want to build studies themselves.
What to consider
Castor has a large published study footprint and strong certifications, and teams can build studies without vendor help. It offers fewer native modules than the enterprise suites, and Everest Group placed it as a Major Contender rather than a Leader in 2024.
Read product profile

Veeva EDC

Best for
Sponsors and CROs already on Veeva's clinical platform who want EDC, RTSM, eCOA and CTMS from the same vendor.
What to consider
Veeva EDC documents mid-study changes and connected clinical applications, and Veeva says eight of the top 20 biopharmas have switched to it. Veeva publishes no study count and no prices.
Read product profile

Compare the features

Both products use the same category definitions. Product order is editorial; products are not ranked.

Full EDC feature comparison

Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.

Expand a feature definition or support note for context and its original source.

Castor vs Veeva EDC (EDC): category feature evidence and sources. Products are not ranked.
Category featureCastorVeeva EDC
Track record in regulated multi-site trials
Feature definitions
Supported
Published product or wider-platform adoption, or a named clinical-research deployment.
Extended support
Product-specific study, customer, institution, site or participant figures plus a published country count establish international use.
Extended support

Castor reports more than 31,900 studies with 9.5 million participants in 171 countries, but its pages give no evidence of global Phase III programs.

Source
About this support label

The vendor reports EDC study and participant figures across a stated country count.

Supported

Veeva reports 100+ EDC customers and says eight of the top 20 biopharmas have switched to Veeva EDC, but publishes no study count.

Source
Study build and mid-study changes
Feature definitions
Supported
Study setup or post-go-live study changes are described.
Extended support
Study setup is described, and post-go-live changes explicitly avoid interrupting live study use.
Supported

Castor offers self-service build with a low-code eCRF builder and reusable templates, and says forms can be edited mid-study with audit trails and separate test environments, without a no-downtime claim.

Source
About this support label

Self-build and audited mid-study edits are stated; uninterrupted live use is not claimed.

Supported

Veeva's white paper states that amendments add new elements without bringing the system down or migrating data, with only a brief casebook lockout while a change deploys.

Source
About this support label

Amendments avoid system shutdown, but deployment includes a brief casebook lockout.

Compliance and security
Feature definitions
Supported
Relevant trial compliance or security controls are stated, with their scope identified.
Extended support
Relevant trial controls and a publicly accessible ISO certificate or SOC audit report covering the product or vendor are documented.
Supported

Castor lists FDA 21 CFR Part 11, EU Annex 11 and ISO 27001 among its compliance standards.

Source
About this support label

Trial standards and ISO certification are listed; public certificate or report access is not established.

Supported

Veeva's trust page lists ISO 27001, ISO 27017, ISO 27018 and a SOC 2 Type II report, and its EDC help docs state that Veeva EDC eSignature meets 21 CFR Part 11.

Source
About this support label

Part 11 eSignature and ISO/SOC statements are given; public certificate or report access is not established.

Platform breadth
Feature definitions
Supported
EDC connects to another named clinical-trial module.
Extended support
Native randomization, trial supply management, medical coding, and either eCOA or ePRO are documented alongside EDC.
Supported

Castor's EDC page lists eConsent, ePRO/eCOA and eSource; it lists no native trial supply management, coding or CTMS.

Source
About this support label

eConsent, ePRO/eCOA and eSource establish connected modules; native supply and coding are not listed.

Supported

Veeva's clinical data suite lists EDC, eCOA, RTSM (randomization and supply) and DQS data management, and Veeva also sells CTMS and eConsent.

Source
About this support label

Connected clinical applications are listed; native medical coding is not established in this note.

APIs and data standards
Feature definitions
Supported
An API for clinical data exchange is stated.
Extended support
An API plus data exchange in a named CDISC format are documented.
Supported

Castor offers an open API, says it aligns with HL7 FHIR and integrates with EHRs, but makes no specific CDISC export claim.

Source
About this support label

An API and FHIR alignment are stated; named CDISC-format exchange is not established.

Supported

Veeva documents a versioned CDMS API for study data, definitions and coding requests with a data model similar to CDISC ODM, but its ODM casebook export is a legacy feature.

Source
About this support label

The API uses an ODM-like model; the only stated ODM export is legacy.

Published pricing and terms
Feature definitions
Supported
A pricing basis, model or contract terms are published beyond contact sales.
Extended support
Production prices or a free production option are published, with amounts and conditions stated.
Supported

No prices published; Castor's pricing page describes an itemized, fixed-scope proposal with change-control terms, sent within five business days.

Source
Unknown

Veeva publishes no EDC prices or pricing model.

Source
About this support label

The note finds neither published prices nor a pricing model.

Unknown does not mean unavailable. The public evidence does not establish support under this category’s definition.

The guide update date reflects guide edits. Vendor statements are attributed in the evidence.

Keep the category in view

Compare these products with the other tools in the EDC guide using the same feature definitions.

More EDC comparisons featuring one of these products.